From January 1, 2024 to March 31, 2024, the company has repurchased 915,000 shares, representing 0.46% for CNY 15.39 million. With this, the company has completed the repurchase of 2,020,000 shares, representing 1.02% for CNY 28.79 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.87 CNY | -1.75% | -6.69% | -22.29% |
1st Jan change | Capi. | |
---|---|---|
-22.29% | 469M | |
+32.14% | 694B | |
+29.39% | 593B | |
-1.57% | 371B | |
+20.01% | 331B | |
+7.09% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.54% | 169B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.